172733-07-2

Basic information

• Product Name: Acetic acid, [[2-ethyl-1-(phenylmethyl)-1H-indol-4-yl]oxy]-, methyl ester
• CAS NO: 172733-07-2
• Molecular Formula: C20H21NO3
• Molecular Weight: 323.392
• Mol File: 172733-07-2.mol
• Article Data: 14

Chemical Properties

• CAS DataBase Reference: Acetic acid, [[2-ethyl-1-(phenylmethyl)-1H-indol-4-yl]oxy]-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Acetic acid, [[2-ethyl-1-(phenylmethyl)-1H-indol-4-yl]oxy]-, methyl ester(172733-07-2)
• EPA Substance Registry System: Acetic acid, [[2-ethyl-1-(phenylmethyl)-1H-indol-4-yl]oxy]-, methyl ester(172733-07-2)

Safety Data

• Hazardous Substances Data: 172733-07-2(Hazardous Substances Data)

Upstream product

• 164082-80-8 1-benzyl-2-ethyl-4-methoxy-1H-indole 
• 96-32-2 bromoacetic acid methyl ester 
• 172733-06-1 1-benzyl-2-ethyl-1H-indol-4-ol 

Downstream Products

• 172733-08-3 [[3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-(phenylmethyl)-1H-indol-4-yl]oxy]acetic acid methyl ester 
• 12125-02-9 ammonium chloride 
• 185298-58-2 2-(1-Benzyl-4-carbamoylmethoxy-2-ethyl-1H-indol-3-yl)-2-oxo-acetamide 
• 172732-68-2 ((3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-(phenylmethyl)-1H-indol-4-yl)oxy)acetic acid 
• 185298-46-8 2-(1-Benzyl-2-ethyl-1H-indol-4-yloxy)-acetamide 
• 1027082-05-8 (1-Benzyl-2-ethyl-1H-indol-4-yloxy)-acetic acid hydrazide 
• 948553-63-7 (1-Benzyl-3-chlorooxalyl-2-ethyl-1H-indol-4-yloxy)-acetic acid methyl ester 

Relevant articles and documents

PHARMACEUTICAL COMPOSITIONS CONTAINING THE PHOSPHOLIPASE INHIBITOR SODIUM 3-(2-AMINO-1,2-DIOXOETHYL)-2-ETHYL-1-PHENYLMETHYL)-1H-INDOL-4-YL]OXY]ACETATE

A lyophilized pharmaceutical composition is described which contains Sodium [[3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-phenylmethyl)-1H-indol-4-yl]oxy]acetate, a Solubilizer, and a Stabilizer. Such compositions are storage stable and readily dissolve in aqueous medium to give injectable solution for treatment of sepsis, etc.

Novel sPLA2 inhibitors

A class of novel indole is disclosed together with the use of such compounds for inhibiting sPLA2 mediated release of fatty acids for treatment of Inflammatory Diseases such as septic shock.

Process for preparing toluenesulfinates

A process for preparing novel compounds useful in the preparation of 1H-indole-3-glyoxamides.